Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component...

Area of Science:

• Immunology
• Vaccinology
• Pediatrics

Background:

• Long-term effectiveness of childhood vaccines is crucial for public health.
• Previous pertussis vaccine efficacy trials established initial protection rates.
• Understanding sustained immunity informs vaccination schedules and disease control strategies.

Purpose of the Study:

• To assess the long-term effectiveness of diphtheria and tetanus toxoids and acellular pertussis (DTaP) and diphtheria and tetanus toxoids and whole-cell pertussis (DTP) vaccines.
• To monitor for decreasing vaccine efficacy over a 6-year follow-up period.
• To compare the sustained immunogenicity of DTaP and DTP vaccines.

Main Methods:

• An open study involving 2924 children who received four doses of DTaP, DTP, or diphtheria and tetanus toxoids (DT) vaccines.
• Standardized questionnaires were administered biannually from 1995 to 2000 to detect clinical pertussis and prolonged cough illnesses.
• Physician confirmation was obtained for all reported cases to determine vaccine efficacy.

Main Results:

• Calculated vaccine efficacy after 6 years showed 89% for DTaP and 92% for DTP against physician-diagnosed pertussis.
• Rates of reported cough illnesses were similar across vaccine groups, indicating no significant reporting bias.
• No evidence of decreasing vaccine efficacy was observed during the follow-up period.

Conclusions:

• Both DTaP and DTP vaccines provide highly effective and sustained protection against pertussis.
• The efficacy of these pertussis vaccines remains robust over an extended duration.
• Findings support the continued use of DTaP and DTP vaccines in childhood immunization programs.